Abstract Number: 477 • 2012 ACR/ARHP Annual Meeting
Impact of Etanercept On Incident Cancer in Taiwanese Patients with Rheumatoid Arthritis
Background/Purpose: The recent Taiwanese report has indicated an elevated risk of malignancy in RA patients1. Etanercept, one of the tumor necrotic factor inhibitors (TNF-I) to…Abstract Number: 1287 • 2012 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Comparison of Active Therapies in Methotrexate Suboptimal Responders: Validation of the Strategy of Conventional Disease Modifying Anti-Rheumatic Drugs Before Biologicals
Background/Purpose: Double-blind placebo controlled randomized trials have demonstrated the efficacy of 15 different therapies in RA patients with active disease despite methotrexate (MTX). No blinded…